Please login to the form below

Porterhouse Medical announces expansion into the US


6 November 2017; Reading, UK – UK-based Porterhouse Medical Ltd is delighted to announce the opening of a subsidiary in Philadelphia, PA, USA. The new entity, Porterhouse Medical US, is to be headed by two experienced medical communications professionals, with a long track record of leading successful businesses in the US.  

Gordon Muir-Jones CMPP, President of Porterhouse Medical US, has, for over 30 years, been directly involved in the development and implementation of multiple global and domestic medical communication plans, with education, publication, training and advocacy components. With particular expertise in publication planning, he is a Charter Member of ISMPP, an active Committee Member, and previous faculty member and expert panelist at TIPPA. Prior to setting up Porterhouse Medical US, Gordon established a US presence for another successful global medical communications consultancy.  

Kevin Ryder PhD, Senior Vice President, has 15 years of experience leading medical communication teams. Also an active member of ISMPP, Kevin has led workshops and panel discussions at national meetings and also served on various committees. Kevin received his doctoral and postdoctoral training in the USA from State University of New York at Stony Brook and Johns Hopkins Medical School, respectively. He held faculty or administrative positions in academic, governmental and non-profit sectors before joining the medical communications field.

Gordon and Kevin will work closely with the joint managing directors of Porterhouse Medical Ltd, Brian Parsons and Jon Hallows, and will have access to a large and experienced team of scientific staff, client service teams, events managers and creatives. Services will include medical writing, publication planning, insights, creative, events, strategy, health economics and market access.

Gordon said, “This is an exciting opportunity for both Kevin and I, as well as for Brian and Jon, and the teams based in the UK. Porterhouse is an outstanding independent agency with a passion for quality and integrity and a set of values to which we all subscribe
Establishing a foothold in the US will provide the company with many more opportunities to work closely with clients that share the same ideals and standards.”

Brian added, “Jon and I had an immediate rapport with Gordon and Kevin and share the same vision for the growth and direction of the Porterhouse Medical Group. The establishment of a subsidiary in the US will help our business reach its potential more rapidly and give our staff more opportunities to address new challenges on a global scale.”  

About Porterhouse Medical Ltd

Established in 2002, Porterhouse Medical Ltd is a scientific and medical communications agency with a reputation for excellence. Our in-house teams of carefully selected scientific staff, account managers, and creatives work hard to deliver imaginative and intelligent communications solutions for a growing number of global pharmaceutical partners based in Europe and the US.  

Our services include: • Medical writing • Publication planning • Insights • Creative • Events • Strategy • Health economics • Market access  

Why do clients choose Porterhouse Medical? Watch our video to find out about our company values, the importance of our people and why our clients love to work with us:

Porterhouse Medical Ltd
Contact: Jane Rodgers
Tel: +44 118 913 9100
Porterhouse Medical Ltd, 4 Windsor Square, Silver St, Reading RG1 2TH, UK  

Porterhouse Medical US

Contact: Gordon Muir-Jones  
Tel: +1 484 808 4477 Porterhouse Medical US, 1,150 First Avenue, Suite 559, King of Prussia, PA 19406, USA  


ISMPP, International Society for Medical Publication Professionals
TIPPA, The International Publication Planning Association.

6th November 2017



Company Details

Porterhouse Medical Group

+44 (0)118 913 9100

Contact Website

4 Windsor Square
Silver Street
United Kingdom

Latest content on this profile

Putting our mission into practice: Porterhouse Medical’s charity round-up 2018 - 2019

Porterhouse Medical Group
Creativity reaches new heights at Porterhouse Medical

Porterhouse Medical Group
Meet Porterhouse Medical at the ISMPP EU meeting 2019 in London 22 - 23 January
Porterhouse Medical’s strategic publication planning experts are participating in two events at the 2019 European Meeting of the International Society for Medical Publication Professionals, entitled: 'Scientific communications in a fast-paced world: Fighting fit for the future'.
Porterhouse Medical Group
Porterhouse Medical Group adds to its growing team of scientific and medical experts

Porterhouse Medical Group
A well-deserved promotion within Porterhouse Medical’s scientific services team

Porterhouse Medical Group
Highlights in haematologic malignancy from ASH 2018
The ASH congress is the most comprehensive haematology event of the year, over 5000 abstracts covering new developments in malignant and non-malignant haematology were presented. Here we focus on two areas of personalised medicine from the oncology setting.
Porterhouse Medical Group